Dyax Corp. (NASDAQ:DYAX)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.
RSS Headlines
Fool UK
Recs
Hot New Products....stock took a beating....when Genzyme deal feel through...This stock due for a nice come back....sell on announcement